Literature DB >> 18639524

Podocalyxin expression in malignant astrocytic tumors.

Norihito Hayatsu1, Mika Kato Kaneko, Kazuhiko Mishima, Ryo Nishikawa, Masao Matsutani, Janet E Price, Yukinari Kato.   

Abstract

Podocalyxin is an anti-adhesive mucin-like transmembrane sialoglycoprotein that has been implicated in the development of aggressive forms of cancer. Podocalyxin is also known as keratan sulfate (KS) proteoglycan. Recently, we revealed that highly sulfated KS or another mucin-like transmembrane sialoglycoprotein podoplanin/aggrus is upregulated in malignant astrocytic tumors. The aim of this study is to examine the relationship between podocalyxin expression and malignant progression of astrocytic tumors. In this study, 51 astrocytic tumors were investigated for podocalyxin expression using immunohistochemistry, Western blot analysis, and quantitative real-time PCR. Immunohistochemistry detected podocalyxin on the surface of tumor cells in six of 14 anaplastic astrocytomas (42.9%) and in 17 of 31 glioblastomas (54.8%), especially around proliferating endothelial cells. In diffuse astrocytoma, podocalyxin expression was observed only in vascular endothelial cells. Podocalyxin might be associated with the malignant progression of astrocytic tumors, and be a useful prognostic marker for astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639524     DOI: 10.1016/j.bbrc.2008.07.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-01-11       Impact factor: 2.916

2.  Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens.

Authors:  Byung Ho Kong; Na-Ri Park; Jin-Kyoung Shim; Bo-Kyung Kim; Hye-Jin Shin; Ji-Hyun Lee; Yong-Min Huh; Su-Jae Lee; Se-Hoon Kim; Eui-Hyun Kim; Eun-Kyung Park; Jong Hee Chang; Dong-Seok Kim; Sun Ho Kim; Yong-Kil Hong; Seok-Gu Kang; Frederick F Lang
Journal:  Childs Nerv Syst       Date:  2012-11-10       Impact factor: 1.475

3.  Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.

Authors:  H-H Cheung; A J Davis; T-L Lee; A L Pang; S Nagrani; O M Rennert; W-Y Chan
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

4.  Identification and expression profiling of blood-brain barrier membrane proteins.

Authors:  Nitin Agarwal; Ethan S Lippmann; Eric V Shusta
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

5.  Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen.

Authors:  Jiyong Kwak; Hye-Jin Shin; Se-Hoon Kim; Jin-Kyoung Shim; Ji-Hyun Lee; Yong-Min Huh; Eui-Hyun Kim; Eun-Kyung Park; Jong Hee Chang; Sun Ho Kim; Yong-Kil Hong; Dong-Seok Kim; Su-Jae Lee; Seok-Gu Kang
Journal:  Childs Nerv Syst       Date:  2013-06-28       Impact factor: 1.475

6.  The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells.

Authors:  Lei Kang; Chunping Yao; Alireza Khodadadi-Jamayran; Weihua Xu; Ruowen Zhang; Nilam Sanjib Banerjee; Chia-Wei Chang; Louise T Chow; Tim Townes; Kejin Hu
Journal:  Stem Cells Dev       Date:  2016-04-01       Impact factor: 3.272

7.  Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.

Authors:  Susan N Thomas; Ronald L Schnaar; Konstantinos Konstantopoulos
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-31       Impact factor: 4.249

Review 8.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-10-05       Impact factor: 2.916

9.  Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

Authors:  A Larsson; M E Johansson; S Wangefjord; A Gaber; B Nodin; P Kucharzewska; C Welinder; M Belting; J Eberhard; A Johnsson; M Uhlén; K Jirström
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

10.  Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide.

Authors:  Hao Wu; Liang Yang; Daguang Liao; Yudan Chen; Wei Wang; Jiasheng Fang
Journal:  Exp Ther Med       Date:  2013-02-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.